News

Net Loss of Transgene Biotek reported to Rs 0.46 crore in the quarter ended March 2026 as against net loss of Rs 0.71 crore during the previous quarter ended March 2025. Sales declined 37.50% to Rs 0.05 crore in the quarter ended March 2026 as against Rs 0.08 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 1.65 crore in the year ended March 2026 as against net loss of Rs 0.68 crore during the previous year ended March 2025. Sales declined 19.23% to Rs 0.21 crore in the year ended March 2026 as against Rs 0.26 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales0.050.08 -38 0.210.26 -19 OPM %-560.00-675.00 --257.14-430.77 - PBDT-0.41-0.69 41 -1.45-0.58 -150 PBT-0.46-0.71 35 -1.65-0.68 -143 NP-0.46-0.71 35 -1.65-0.68 -143 Powered by Capital Market - Live News

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net Loss of Transgene Biotek reported to Rs 0.37 crore in the quarter ended December 2025 as against net loss of Rs 0.09 crore during the previous quarter ended December 2024. Sales declined 37.50% to Rs 0.05 crore in the quarter ended December 2025 as against Rs 0.08 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.050.08 -38 OPM %-100.00-112.50 - PBDT-0.32-0.07 -357 PBT-0.37-0.09 -311 NP-0.37-0.09 -311 Powered by Capital Market - Live News

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News

Transgene Biotek announced that the 35th Annual General Meeting(AGM) of the company will be held on 30 December 2025.Powered by Capital Market - Live News